Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid... (eased the inflammatory response in multi...)

Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis

Date:8/4/2009

eased the inflammatory response in multiple models of arthritis, inflammation and transplantation.

The Phase 2 clinical trial is designed as a 12-week, randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of LX2931 and its effects on symptoms associated with rheumatoid arthritis. The study will include multiple centers in the United States and Eastern Europe. The company expects to enroll up to 120 patients with rheumatoid arthritis on stable methotrexate therapy. Three dose levels will be evaluated: a 70 mg dose, a 110 mg dose and a 150 mg dose, each administered once daily. The primary endpoint will be the ACR20, which is defined by the American College of Rheumatology (ACR) as a 20 percent improvement in symptoms associated with rheumatoid arthritis. Multiple secondary endpoints will also be evaluated, including ACR50, ACR70 and DAS28.

In addition to LX2931, Lexicon has two other drug candidates progressing in Phase 2 clinical trials, LX1031 for irritable bowel syndrome and LX1032 for carcinoid syndrome. Furthermore, LX4211 for diabetes has recently completed dosing in a Phase 1 clinical trial. For more information about Lexicon's clinical development programs, please visit www.lexpharma.com.

About Rheumatoid Arthritis

Lymphocytes are a type of white blood cell that play an important role in the immune system. Inappropriate activation of lymphocytes is often associated with autoimmune diseases, a spectrum of disorders in which the immune system malfunctions and causes the body to attack its own organs, tissues and cells. Rheumatoid arthritis is an autoimmune disorder characterized by stiffness, pain, swelling, and limitation of motion in multiple joints. More than 2 million Americans suffer from rheumatoid arthritis, which, if left untreated, can result in disfigurement and disabilit
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
2. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
3. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
4. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
5. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Harbinger Research Initiates Coverage on HearAtLast
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
10. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
11. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent

Post Your Comments:

(Date:12/15/2009)... Consumer Watchdog Calls For Preserving State Authority, Ban ... ,, WASHINGTON, Dec. 15 Consumer ... provision for those over 55 and the public ... But the group said that the Senate must ... weakened bill to prevent ceding the entire health ...

(Date:12/15/2009)... Senator earns lump of coal for lying about taxes in ... -- Sen. Max Baucus has earned a place under the ... and Nice List after being caught telling a brazen ... that the Senate healthcare bill would not raise taxes. ... Baucus said: ,, " I ...

(Date:12/15/2009)... Incidence fell in area where all couples of reproductive ... 14 (HealthDay News) -- The number of children born ... who might be CF mutation carriers increases, a new ... in an area of northeast Italy for many years. ... progressive decline in the number of infants born with ...

(Date:12/15/2009)... American Diabetes Association and the CDC have released some sobering statistics ... United States. Treadmill desks offer employers an effective means of combating ... ... (Vocus) December 14, 2009 -- Rates of diabetes are climbing across ... obesity rates. Despite this rise the American Diabetes Association has stated ...

(Date:12/15/2009)... -- 4R Systems, Inc., a leading provider of ... retailers significantly increase profits by optimizing their inventory ... The Vitamin Shoppe has been utilizing the 4R ... DC inventory solutions have helped us drive significant ... the last two years," said Tony Truesdale, President ...

Breaking Medicine News(10 mins):Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2 Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3 Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4 Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5 Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2 Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3 Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2 Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2 Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4

[1] The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System [0] ATR: Baucus Earns Place on 2009 "Naughty" List [0] Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis [2] TrekDesk: A Potentially Positive Impact on Diabetes & Obesity [1] 4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance

... ST. PETERSBURG, Fla., Jan. 14 Smith & Nephew,s Advanced ... announced that on Tuesday, the Specialist Patents Court in the ... Concepts, Inc (NYSE: KCI ) a temporary injunction ... negative pressure wound therapy in the United Kingdom. The temporary ...

... Jan. 14 /PRNewswire-Asia-FirstCall/ -- SOKO Fitness & Spa,Group, Inc. ... clubs,and spas in Northern China, today announced its operating ... , Total revenue for the ... the prior year. For the six months ended ...

... those over 40 who want a baby, study says, , , WEDNESDAY, ... cycles of in vitro fertilization have up to an 86 percent ... women over 40, the odds are less than 50 percent -- ... the treatment of infertility, and it can overcome most causes of ...

... Demonstrates Treatment Success, and Highlights Potential Factors that Affect ... C - NUTLEY, N.J., Jan. 14 Results from ... Latino patients with the hepatitis C virus (HCV), were ... Medicine (NEJM).(1) This Roche study demonstrated that HCV ...

... Study finds it has led to a considerable reduction ... -- Rates of pneumococcal meningitis, a potentially life-threatening infection, ... in 2000, a new study shows. , The declines ... vaccine but also in adults, suggesting a herd immunity ...

... PALO ALTO, Calif., Jan. 14 Home Care ... to ensure that franchisees,achieve consistently high rankings in ... the Internet. This strategy that delivers thousands of,leads ... is,rooted in the company,s commitment to provide solutions ...

Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom SOKO Fitness & Spa Group Announces Second Quarter FY2009 Financial Results IVF Treatments Often Work for Women Under 35 PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine Meningitis Vaccine Seems to Work Like a Charm Home Care Franchise Forms Strategic Partnership with Google(TM)

(Date:12/15/2009)... 15 Ever wonder what something looks like ... makers of the Personal Scanning Electron Microscope (PSEM), kicked ... to send in samples to be scanned by one ... a scan range of 100nm to 5mm and an ... samples into focus. In addition, ASPEX will not only ...

(Date:12/15/2009)... 15 A Harvard medical expert internationally recognized ... the PGA Tour,s decision last month to suspend ... diagnosed him as having the medical condition ... condition is "unreasonable, unfair and discriminatory." ,, ... normal testosterone levels, often referred to informally as ...

(Date:12/15/2009)... -- Certified healthcare providers who have already immunized ... H1N1 flu virus may now offer the vaccine ... Health announced today. ,, Pennsylvania is expanding ... 3.2 million doses of vaccine have been allocated ... in the priority groups. ,, "Many certified providers ...

Breaking Medicine Technology:ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2 Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2 Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3 Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4 Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2 Weill Cornell science briefs 3A November 2009 10815 1 Weill Cornell science briefs 3A November 2009 10815 2 Weill Cornell science briefs 3A November 2009 10815 3 Weill Cornell science briefs 3A November 2009 10815 4 Weill Cornell science briefs 3A November 2009 10815 5 Astor Group Expands Healthcare Practice With Hiring of Chris Dimitropoulos 61740 1 Astor Group Expands Healthcare Practice With Hiring of Chris Dimitropoulos 61740 2 Thought Controlled Game 3B Jedi Mind Inc Provides Update on Progress 61736 1 Thought Controlled Game 3B Jedi Mind Inc Provides Update on Progress 61736 2

[0] ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign [0] Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory'[0] Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients

... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced ... gout will be reviewed by the Arthritis Advisory Committee appointed ... 5, 2009 as required for a drug of a new ... the FDA on October 31, 2008 seeking approval to market ...

... Omeros Corporation today announced that it was awarded ... and grant funding from The Stanley Medical Research ... the Company,s proprietary product candidates for the treatment ... payment to Omeros for having successfully met preclinical ...

Other Medicine Technology:Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 2 Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 3 Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 4 Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program 2

Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

Medicine Products:

Indocybin Indirect Coombs Indicans, Urine Qualitative India Ink Exam

Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid...(eased the inflammatory response in multi...),Health